Christopher Stevens's most recent trade in Rocket Pharmaceuticals Inc was a trade of 36,658 Common Stock done at an average price of $3.5 . Disclosure was reported to the exchange on Aug. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 11 Aug 2026 | 36,658 | 505,784 (0%) | 0% | 3.5 | 128,266 | Common Stock |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2026 | 101,428 | 101,428 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2026 | 73,313 | 542,442 (1%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 93,037 | 93,037 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 61,963 | 469,129 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 554,071 | 554,071 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Christopher Stevens | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 407,166 | 407,166 (0%) | 0% | 0 | Common Stock |